Clostridioides difficile infection (CDI) is one of the most common and severe nosocomial
infections worldwide. It can also affect healthy individuals in the community. The incidence of …

Clostridioides difficile (C. difficile, previously known as Clostridium difficile) infections are a
major health care concern. The Centers for Disease Control and Prevention (CDC) …

Clostridioides difficile remains a problematic pathogen resulting in significant morbidity and
mortality, especially for high-risk groups that include immunocompromised patients. Both the …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Clostridioides difficile is an increasingly common pathogen both within and outside the
hospital and is responsible for a large clinical spectrum from asymptomatic carriage to …

Background Clostridioides difficile is the most common cause of healthcare‐associated
infection, and severe cases can result in significant complications. While anti‐microbial …

Clostridioides difficile is an obligate, anaerobic, spore-forming, gram-positive bacillus that
populates the intestines of approximately 5% to 10% of healthy humans and is acquired in …

The infection caused by Clostridioides difficile represents one of the bacterial infections with
the greatest increase in incidence among nosocomial infections in recent years. C. difficile is …

Introduction Clostridioides difficile infection (CDI) is a major healthcare problem in the
developed world, and effective management of recurrent infection remains one of the …

Since the implementation of innovative treatment options for the management of CDIs during
the recent decades, controversy exists regarding the most cost-effective treatment pathways …